GT Biopharma (GTBP) Return on Capital Employed [ROCE] (2017 - 2026)
GT Biopharma (GTBP) posted Return on Capital Employed [ROCE] of -201.02% for Q1 2026, up 117.94 percentage points from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends
For FY2025, GT Biopharma's Return on Capital Employed [ROCE] came in at -322.65%, up 116.82 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a four-year change of +341.80 percentage points (FY2021 to FY2025).
- In prior years, GT Biopharma's Return on Capital Employed [ROCE] was -439.47% in FY2024 (-285.01 pp), -154.46% in FY2023 (-45.53 pp), -108.93% in FY2022 (+555.52 pp) and -664.45% in FY2021.
- The Q1 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2024.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2022, with a gain of 90.22 percentage points; the weakest was Q2 2022, with a drop of 110.42 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.86% |
| 10 | GT Biopharma | 7.68 Mn | -15.81 Mn | - | -201.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -201.02% |
| Dec 31, 2025 | -318.96% |
| Sep 30, 2025 | -240.60% |
| Mar 31, 2024 | -175.45% |
| Dec 31, 2023 | -159.80% |
| Sep 30, 2023 | -134.26% |
| Jun 30, 2023 | -140.74% |
| Mar 31, 2023 | -135.89% |
| Dec 31, 2022 | -152.21% |
| Sep 30, 2022 | -191.28% |
| Jun 30, 2022 | -189.53% |
| Mar 31, 2022 | -167.26% |
| Dec 31, 2021 | -242.43% |
| Sep 30, 2021 | -82.94% |
| Jun 30, 2021 | -79.10% |
| Mar 31, 2021 | -162.51% |
| Jun 30, 2019 | -2,745.02% |
| Mar 31, 2019 | -2,483.06% |
| Dec 31, 2018 | -2,094.64% |
| Sep 30, 2018 | -198.25% |
API Access
GT Biopharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();